Yangyang Yao

1.2k total citations
44 papers, 552 citations indexed

About

Yangyang Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yangyang Yao has authored 44 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Yangyang Yao's work include Hippo pathway signaling and YAP/TAZ (6 papers), Connective tissue disorders research (5 papers) and Ferroptosis and cancer prognosis (5 papers). Yangyang Yao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (6 papers), Connective tissue disorders research (5 papers) and Ferroptosis and cancer prognosis (5 papers). Yangyang Yao collaborates with scholars based in China, United Kingdom and Australia. Yangyang Yao's co-authors include Jianping Xiong, Shanshan Huang, Hui Guo, Xiaojun Xiang, Jun Deng, Jun Deng, Jun Chen, Junhe Li, Xiaoyu Li and Ping Xie and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and Molecules.

In The Last Decade

Yangyang Yao

41 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangyang Yao China 15 330 146 83 55 53 44 552
Jiaxiang Chen China 15 388 1.2× 102 0.7× 100 1.2× 90 1.6× 19 0.4× 33 623
Yong Han China 15 369 1.1× 245 1.7× 98 1.2× 84 1.5× 31 0.6× 53 683
Ji Yun Lee South Korea 14 373 1.1× 55 0.4× 81 1.0× 34 0.6× 46 0.9× 32 584
Cong Niu China 12 330 1.0× 80 0.5× 37 0.4× 63 1.1× 37 0.7× 19 460
Minghua Li China 13 285 0.9× 157 1.1× 47 0.6× 30 0.5× 23 0.4× 22 483
Yuying Zhou China 12 186 0.6× 55 0.4× 37 0.4× 32 0.6× 31 0.6× 35 468
Young‐Joon Hong South Korea 11 244 0.7× 81 0.6× 79 1.0× 25 0.5× 23 0.4× 20 498

Countries citing papers authored by Yangyang Yao

Since Specialization
Citations

This map shows the geographic impact of Yangyang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Yao more than expected).

Fields of papers citing papers by Yangyang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Yao. The network helps show where Yangyang Yao may publish in the future.

Co-authorship network of co-authors of Yangyang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Yao. A scholar is included among the top collaborators of Yangyang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Yao. Yangyang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jingyi, Wen Qin, Wei Jin, et al.. (2025). TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. Cell Death and Disease. 16(1). 287–287. 3 indexed citations
3.
4.
Zhao, Wan‐Yi, Yan Sun, Yanzhou Wang, et al.. (2024). Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2242–2255. 1 indexed citations
5.
Dai, Xiaofeng, Zhipeng Wu, Jingyi Chen, et al.. (2024). TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer. Cell Communication and Signaling. 22(1). 168–168. 6 indexed citations
6.
Li, Tianyou, et al.. (2024). The role of the cartilaginous to osseous acetabular angle ratio in children with developmental dysplasia of the hip. Frontiers in Pediatrics. 12. 1347556–1347556.
7.
Yao, Yangyang, Zhen Liu, Shanshan Huang, et al.. (2022). The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway. Cell Death Discovery. 8(1). 79–79. 32 indexed citations
8.
Yao, Yangyang, et al.. (2022). Cell‐Dependent Pathogenic Roles of Filamin B in Different Skeletal Malformations. Oxidative Medicine and Cellular Longevity. 2022(1). 8956636–8956636. 2 indexed citations
9.
Yang, Xinjian, et al.. (2022). Verification of software-based preoperative simulation of flow diverters in clinical cases. Interventional Neuroradiology. 29(5). 510–519. 1 indexed citations
10.
Yao, Yangyang, et al.. (2022). Genotype-Phenotype Relationship and Follow-up Analysis of a Chinese Cohort With Osteogenesis Imperfecta. Endocrine Practice. 28(8). 760–766. 6 indexed citations
11.
Guo, Hai, et al.. (2021). Obstructive sleep apnea and incidence of malignant tumors: a meta-analysis. Sleep Medicine. 84. 195–204. 20 indexed citations
12.
Zhong, Min, Ling Zhou, Zhi Fang, et al.. (2021). Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway. World Journal of Gastroenterology. 27(26). 4221–4235. 26 indexed citations
13.
Huang, Shanshan, Yuan Cao, Hui Guo, et al.. (2020). Up‐regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1‐AGK–positive loop. Journal of Cellular and Molecular Medicine. 24(19). 11133–11145. 13 indexed citations
14.
Li, Li, Shanshan Huang, Yangyang Yao, et al.. (2020). Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. World Journal of Surgical Oncology. 18(1). 324–324. 16 indexed citations
15.
Yao, Yangyang, Zhen Liu, Yuan Cao, et al.. (2020). Downregulation of TRIM27 suppresses gastric cancer cell proliferation via inhibition of the Hippo-BIRC5 pathway. Pathology - Research and Practice. 216(9). 153048–153048. 13 indexed citations
16.
Zhu, Lingling, Shanshan Huang, Junhe Li, et al.. (2020). Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways. Gene. 742. 144556–144556. 33 indexed citations
17.
Hong, Yang, Yangyang Yao, Hui-Yun Gu, et al.. (2019). The Clinical Benefit of Device Therapy for Meniere’s Disease in Adults: Systematic Review and Meta-Analysis. The Journal of International Advanced Otology. 15(1). 121–129. 5 indexed citations
18.
Yao, Yangyang & Tianyou Li. (2019). Current status of surgery for osteogenesis imperfecta. Zhonghua xiaoerwaike zazhi. 40(11). 1052–1056. 1 indexed citations
19.
Yao, Yangyang, Lu‐Lu Lin, Hui-Yun Gu, et al.. (2019). Are Corticosteroids Beneficial for Sepsis and Septic Shock? Based on Pooling Analysis of 16 Studies. Frontiers in Pharmacology. 10. 714–714. 12 indexed citations
20.
Yao, Yangyang, Zhen Liu, Hui Guo, et al.. (2018). Elevated TRIM23 expression predicts poor prognosis in Chinese gastric cancer. Pathology - Research and Practice. 214(12). 2062–2068. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026